Identifying factors associated with persistent opioid use after total joint arthroplasty: a retrospective review - Scorecard - MDSpire

Identifying factors associated with persistent opioid use after total joint arthroplasty: a retrospective review

  • By

  • Aurora Quaye

  • John DiPalazzo

  • Kristin Kostka

  • Janelle M Richard

  • Blaire Beers-Mulroy

  • Meredith Peck

  • Robert Krulee

  • Yi Zhang

  • November 20, 2024

  • 0 min

Share

Clinical Scorecard: Examining Predictors of Ongoing Opioid Use Following Total Joint Arthroplasty: A Retrospective Analysis

At a Glance

CategoryDetail
ConditionPersistent opioid use after total joint arthroplasty
Key MechanismsPostoperative pain management with opioids; patient-specific risk factors influencing prolonged opioid use
Target PopulationOpioid-naïve adults undergoing total knee, hip, or shoulder arthroplasty
Care SettingOrthopedic surgical and postoperative care within a health system

Key Highlights

  • 12.3% of opioid-naïve patients developed persistent opioid use defined as opioid prescription between 90 days and 1 year post-surgery.
  • Significant predictors of persistent opioid use include current smoking, antidepressant use, PTSD, substance-related disorders, back pain, dementia, and BMI >40.
  • Age, sex, and ethnicity were not associated with persistent opioid use risk.

Guideline-Based Recommendations

Diagnosis

  • Identify opioid-naïve patients scheduled for total joint arthroplasty.
  • Assess patient history for smoking status, mental health diagnoses (PTSD, substance-related disorders), antidepressant use, back pain, dementia, and BMI.

Management

  • Use predictive models to stratify patients by risk of persistent opioid use preoperatively.
  • Implement targeted interventions to reduce opioid reliance in high-risk patients.
  • Consider multimodal pain management strategies and perioperative regional anesthesia to potentially reduce long-term opioid use.

Monitoring & Follow-up

  • Monitor opioid prescriptions from discharge through at least 1 year post-surgery.
  • Follow up regularly to assess pain control and opioid use patterns.
  • Track patients with identified risk factors closely for signs of prolonged opioid use.

Risks

  • Persistent opioid use increases risk of postoperative infection, revision arthroplasty, opioid dependence, and increased healthcare costs.

Patient & Prescribing Data

Opioid-naïve adults undergoing primary total joint arthroplasty (knee, hip, shoulder).

Persistent opioid use occurred in 12.3% of patients; risk factors include smoking, mental health disorders, high BMI, and chronic pain conditions, highlighting the need for preoperative risk assessment.

Clinical Best Practices

  • Exclude patients with prior opioid use to accurately identify new persistent opioid use risk factors.
  • Use validated predictive models such as LASSO logistic regression for risk stratification.
  • Focus on preoperative identification of modifiable risk factors to tailor pain management plans.
  • Avoid prolonged opioid prescriptions post-discharge when possible and promote alternative analgesic strategies.
  • Provide patient education on risks of long-term opioid use and set realistic expectations for postoperative pain.

References

Original Source(s)

Related Content